EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The HDAC1 inhibitor attenuates renal ischemia–reperfusion injury via dual epigenetic modulation of p53 and macrophage NF-κB pathways

Qian-Qian Zhang, Chen-Zhen Yu, Fei-Hong Yu, Yong-Bo Wang, Song Chen, Zhong-Hua Klaus Chen, Wei-Jie Zhang, Sheng Chang

Cell Biology and Toxicology · 11.05.2026 · 42 (1)

DOI: 10.1007/s10565-026-10202-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 11.05.2026. Verfasst von Qian-Qian Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ T…. Hauptthemen laut MEDLINE: Reperfusion Injury, Histone Deacetylase 1, Macrophages, Tumor Suppressor Protein p53. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryHistone Deacetylase 1MacrophagesTumor Suppressor Protein p53NF-kappa BHistone Deacetylase InhibitorsEpigenesis, GeneticAnimalsSignal TransductionApoptosisMiceMaleEpithelial CellsMice, Inbred C57BLKidneyDepsipeptides

Stichwörter der Autor:innen

ApotosisEpigeneticsHDACIRIMacrophage

Substanzen

Histone Deacetylase 1Tumor Suppressor Protein p53NF-kappa BHistone Deacetylase InhibitorsHdac1 protein, mouseromidepsinDepsipeptides

Autor:innen und Institutionen

  • Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education NHC Key Laboratory of Organ Tran…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Zhang, Q. Q., Yu, C. Z., Yu, F. H., Wang, Y. B., Chen, S., Chen, Z. K., Zhang, W. J., & Chang, S. (2026). The HDAC1 inhibitor attenuates renal ischemia–reperfusion injury via dual epigenetic modulation of p53 and macrophage NF-κB pathways. Cell Biology and Toxicology, 42(1). https://doi.org/10.1007/s10565-026-10202-2

Vancouver

Zhang QQ, Yu CZ, Yu FH, Wang YB, Chen S, Chen ZK, et al. The HDAC1 inhibitor attenuates renal ischemia–reperfusion injury via dual epigenetic modulation of p53 and macrophage NF-κB pathways. Cell Biology and Toxicology. 2026;42(1). doi:10.1007/s10565-026-10202-2

BibTeX
@article{Zhang2026,
  author = {Zhang, Qian-Qian and Yu, Chen-Zhen and Yu, Fei-Hong and Wang, Yong-Bo and Chen, Song and Chen, Zhong-Hua Klaus and Zhang, Wei-Jie and Chang, Sheng},
  title = {The HDAC1 inhibitor attenuates renal ischemia–reperfusion injury via dual epigenetic modulation of p53 and macrophage NF-κB pathways},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  volume = {42},
  number = {1},
  doi = {10.1007/s10565-026-10202-2}
}
Kostenlos starten →